A diary of the thought process behind my investment decisions
All Good Things
All good thing must come to an end. It seems the run in pharmaceuticals stocks is over for now as Pfizer sells off on "better than expected" earnings. I disposed of the trading portion of my pharma positions yesterday, but I still hold the much larger longer term position. I remain a believer in the sector but nothing goes up or down in a straight line. Except for the market in the past six months.